Literature DB >> 8960349

Phosphorylation of the carboxyl-terminal region of dystrophin.

M Michalak1, S Y Fu, R E Milner, J L Busaan, J E Hance.   

Abstract

Dystrophin is a protein product of the gene responsible for Duchenne and Becker muscular dystrophy. The protein is localized to the inner surface of sarcolemma and is associated with a group of membrane (glyco)proteins. Dystrophin links cytoskeletal actins via the dystrophin-associated protein complex to extracellular matrix protein, laminin. This structural organization implicates the role of dystrophin in stabilizing the sarcolemma of muscle fibers. Precisely how dystrophin functions is far from clear. The presence of an array of isoforms of the C-terminal region of dystrophin suggests that dystrophin may have functions other than structural. In agreement, many potential phosphorylation sites are found in the C-terminal region of dystrophin, and the C-terminal region of dystrophin is phosphorylated both in vitro and in vivo by many protein kinases, including MAP kinase, p34cdc2 kinase, CaM kinase, and casein kinase, and is dephosphorylated by calcineurin. The C-terminal domain of dystrophin is also a substrate for hierarchical phosphorylation by casein kinase-2 and GSK-3. These observations, in accordance with the finding that the cysteine-rich region binds to Ca2+, Zn2+, and calmodulin, suggest an active involvement of dystrophin in transducing signals across muscle sarcolemma. Phosphorylation-dephosphorylation of the C-terminal region of dystrophin may play a role in regulating dystrophin-protein interactions and (or) transducing signal from the extracellular matrix via the dystrophin molecule to the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960349     DOI: 10.1139/o96-047

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  Dp71f modulates GSK3-beta recruitment to the beta1-integrin adhesion complex.

Authors:  Joel Cerna Cortés; Eliud Alfredo Garcia Montalvo; Jesús Muñiz; Dominique Mornet; Efrain Garrido; Federico Centeno; Bulmaro Cisneros
Journal:  Neurochem Res       Date:  2008-08-02       Impact factor: 3.996

Review 2.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

3.  Phosphorylation of kinase-related protein (telokin) in tonic and phasic smooth muscles.

Authors:  M A Krymsky; D S Kudryashov; V P Shirinsky; T J Lukas; D M Watterson; A V Vorotnikov
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  What Are the bona fide GSK3 Substrates?

Authors:  Calum Sutherland
Journal:  Int J Alzheimers Dis       Date:  2011-05-18

Review 5.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

6.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Authors:  Kristy Swiderski; Scott A Shaffer; Byron Gallis; Guy L Odom; Andrea L Arnett; J Scott Edgar; Dale M Baum; Annabel Chee; Timur Naim; Paul Gregorevic; Kate T Murphy; James Moody; David R Goodlett; Gordon S Lynch; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

7.  Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy.

Authors:  Joseph G Reynolds; Sarah A McCalmon; Julie A Donaghey; Francisco J Naya
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

8.  GSK-3: Functional Insights from Cell Biology and Animal Models.

Authors:  Oksana Kaidanovich-Beilin; James Robert Woodgett
Journal:  Front Mol Neurosci       Date:  2011-11-16       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.